decisionhealth Newsletters, Part B News - 2017 Issue 2 (February)
Brief: New rule updates protections for patients in clinical trials
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a final federal rule from HHS and other departments that updates protections for people involved in medical research. It covers the broad reasons for the update, including technology changes, secondary research data use, and the growth of clinical trials outside hospital settings, along with general areas of procedural revision such as informed consent and institutional review board requirements. The piece is relevant to healthcare organizations, research staff, compliance teams, and anyone tracking federal research policy.
Why This Topic Matters
Changes to the Common Rule can affect how clinical research is reviewed, consented, and overseen across many care settings. Readers need a high-level understanding of the regulatory update to assess operational and compliance impact.
What You Will Learn
- What the final rule is about
- Why the federal update was issued
- Which broad research oversight processes are affected
- How the article frames the relevance of the rule for clinical research settings
Who Should Read This
- Healthcare compliance professionals
- Clinical research administrators
- Institutional review board staff
- Physician office practice managers
- Researchers and study coordinators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com